Despite the massively increased copy number of MYCN in these cells, MYCN expression levels were extremely sensitive to ATRA treatment and became profoundly down-regulated following collapse of the adrenergic CRC required to drive its expression. The gene discussed is MYCN; the disease is colorectal carcinoma.